Sign In

Rick Finnegan

Chief Business Officer, EVP Program Management

Professional Background

Rick Finnegan has established himself as a highly accomplished business leader and expert in the biopharmaceutical industry. As the Chief Business Officer and EVP of Program Management at SAB Biotherapeutics, Rick plays a crucial role in driving the organization's strategic initiatives and advancing its mission in biotherapeutics. His extensive career spans over several key leadership positions in various respected organizations, emphasizing his versatility and deep insights into the complex landscape of the biopharmaceutical sector.

Previously, Rick excelled as the CEO at rEVO Biologics, where he was pivotal in steering the company towards innovative biotechnology solutions. His tenure there also combined roles as the Senior Vice President of Operations and Program Management, positioning him at the intersection of operational excellence and strategic growth. Furthermore, Rick's role as Executive Vice President of Global Strategic Accounts and Commercial Development at inVentiv Health showcased his remarkable ability to forge strategic partnerships and drive commercial success, benefitting both clients and the companies he has led.

In addition to his executive roles, Rick's impressive background includes serving as President of Specialty Pharma, Europe at Glenmark Pharmaceuticals, where he oversaw operations in a key regional market. His tenure at GTC Biotherapeutics as VP of Corporate Development allowed him to focus on strategic business development and enhance product pipelines through innovative methodologies. With significant experience in sales and marketing, Rick’s previous positions encompassed leadership roles at Critical Therapeutics and Genzyme, where he made significant strides in harnessing market opportunities for various therapeutic products. His role as Global Franchise Lead for Anti-infectives at Merck further exemplifies his deep understanding of market dynamics and his ability to lead teams towards achieving ambitious sales goals.

Rick honed his marketing and product management expertise through several key roles at Merck, where he developed pioneering strategies for major products like FOSAMAX and PROSCAR. His journey at Merck commenced with an entry-level Associate position in the International Marketing Management Training Program, which laid a strong foundation for his impressive career in the pharmaceutical industry. Rick's ability to navigate complex healthcare markets has paved the way for significant business growth and innovative solutions throughout his career.

Education and Achievements

Rick Finnegan earned his Master of Science (MS) degree from the prestigious Massachusetts Institute of Technology - Sloan School of Management, a renowned institution that has produced some of the world's leading business minds. This advanced education provided Rick with vital skills in leadership, management strategy, and innovative thinking, all of which he applies to his roles in the dynamic biopharmaceutical sector.

Additionally, he holds a Bachelor of Science (BS) degree from the University of New Hampshire's Whittemore School of Business and Economics, where he laid the groundwork for his successful management career. The combination of practical school experiences and advanced education has made Rick a well-rounded leader capable of tackling the industry's challenges while driving teams toward sustained success.

Notable Achievements

In his career, Rick Finnegan has consistently achieved impressive milestones that underscore his dedication to the biotherapeutics field. His leadership at SAB Biotherapeutics has been characterized by innovative program management strategies that leverage advanced scientific research to create valuable health solutions. His work has not only facilitated organizational growth but has also contributed to advancements in patient care.

Rick’s accomplishments at rEVO Biologics included successful product launches and the implementation of operational protocols that enhanced product development timelines, a critical factor in the fast-paced biopharmaceutical sector. By focusing on strategic partnerships and aligning development processes with market needs, he has significantly impacted the effectiveness of product offerings. At Glenmark Pharmaceuticals, Rick’s leadership helped navigate the complexities of the European market, ultimately contributing to the company's robust positioning as a leading global biopharmaceutical organization.

Rick’s sales and marketing expertise, particularly in his roles at Merck, played a crucial part in successful product management. His ability to launch and market high-impact products laid the groundwork for robust revenue streams that benefited Merck and, ultimately, patients around the world.

In summary, Rick Finnegan’s career embodies a strong blend of leadership, strategic marketing, and operational excellence in the biopharmaceutical sector. Through his educational background and extensive professional experience, Rick has emerged as an influential figure in the industry, driving innovation and growth while remaining dedicated to improving healthcare outcomes. His journey reflects not only the importance of expertise in business and management but also a commitment to advancing therapeutic solutions that enhance patients' lives.

Related Questions

How did Rick Finnegan develop his expertise in the biopharmaceutical industry?
What innovative strategies did Rick Finnegan implement during his tenure at SAB Biotherapeutics?
How has Rick Finnegan's education from MIT Sloan impacted his career in management?
What key milestones did Rick achieve while serving as CEO at rEVO Biologics?
How has Rick Finnegan's role at Glenmark Pharmaceuticals shaped his understanding of global markets?
R
Add to my network

Location

Greater Boston